drugset / Trial / NCT03827876
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
NaSingle-groupOpen-labelTreatment
Summary
4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to patients with 2-10% BSA who are receiving etanercept or adalimumab for at least 24 weeks
Timeline
- Start
- 2019-01-16
- Primary completion
- 2019-09-15
- Completion
- 2019-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcipotriol | Small molecule | 0.005 % | Topical |
| Subject | betamethasone dipropionate | Small molecule | 0.064 % | Topical |